The new APN inhibitors 4cc and 24F were shown to be anti-cancer agents for HCC by activating mitochondrial apoptosis pathways and inhibiting HCC cell invasion and angiogenesis (52, 53). Here, ANPEP is linked to hepatocellular carcinoma.